遺伝子発現解析市場の2030年までの予測：製品別、技術別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の遺伝子発現解析市場は2023年に49億米ドルを占め、予測期間中のCAGRは10.8％で成長し、2030年には100億米ドルに達すると予測されています。

遺伝子発現解析とは、遺伝子がRNAに転写され、タンパク質に翻訳される過程、あるいは遺伝子がコードする機能産物の研究を指します。特定の条件下で、特定の細胞、組織、生物における遺伝子の活性を測定します。遺伝子発現解析は、発生、分化、刺激に対する応答、疾患など、さまざまな生物学的プロセスの根底にある分子メカニズムの理解に役立ちます。遺伝子発現パターンを調べることで、研究者は特定の経路に関与する主要遺伝子を特定し、遺伝子がどのように制御されているかを明らかにし、疾患の分子基盤に関する洞察を得ることができます。

インド商工会議所連合会（FICCI）が2016年に実施した調査によると、インドではバイオテクノロジー分野において、博士号取得者と博士号取得後の科学者が80％近く、修士号取得者が20％、生産スタッフが18％不足しています。

個別化医療の採用拡大

個別化医療の採用が急増しており、個人の遺伝子プロファイルに基づいて治療法を調整することが重視されています。この動向は、遺伝子発現パターンをより正確に解析できるようになったゲノム研究と技術の進歩によってもたらされています。ヘルスケアプロバイダーが個別化アプローチの価値を認識するようになるにつれ、市場はさらに拡大し、オーダーメイドの治療や診断のための革新的なソリューションが提供されるようになると予想されます。

訓練を受けた専門家の不足

遺伝子発現データの解釈と解析における熟練した専門家の需要は、現在の労働力供給をはるかに上回っています。この不足は、疾患の理解と標的治療の開発においてゲノミクスの可能性を最大限に活用する上で大きな課題となります。この分野を前進させ、ヘルスケアとライフサイエンスにおける遺伝子発現解析の革新的な能力を解き放つためには、教育とトレーニングのイニシアティブを通じてこのギャップに対処することが極めて重要です。同市場は訓練を受けた専門家の深刻な不足に直面しており、ゲノム研究と診断の進歩を妨げています。

急速な技術進歩

ハイスループットシーケンス、シングルセル解析、バイオインフォマティクスにおける技術革新は、遺伝子発現解析をかつてないレベルの精度と効率へと押し上げました。遺伝子発現解析技術の絶え間ない進化は、精密医療を進歩させ、遺伝子制御に関する我々の理解を一変させる大きな可能性を秘めています。市場は急速な技術進歩を目の当たりにし、細胞機能の理解に革命をもたらしています。

装置の高コスト

遺伝子発現解析に必要な高度な技術と専門的な機器は、高価格の一因となっています。この経済的障壁は、小規模な研究所や研究施設が包括的な遺伝子発現研究に十分に取り組むことを制限し、この分野における科学的進歩の包括性と進歩に影響を与える可能性があります。コストの問題に対処することは、遺伝子発現解析研究への幅広い参加と技術革新を促進する上で極めて重要です。装置の高コストが市場の成長を阻害する要因です。

COVID-19の影響：

COVID-19の流行は市場に大きな影響を与えました。ウイルスの分子メカニズムの解明への注目が高まり、遺伝子発現解析ツールの需要が高まった。しかし、サプライチェーンの混乱、研究所の閉鎖、研究資金の減少が課題となっています。市場は、感染症研究への優先順位のシフトに伴い、急増と減少の両方を目の当たりにしてきました。この分野の企業が不確実性を乗り越えて勢いを維持するには、リモートワークやデジタルソリューションへの対応が不可欠となっています。

予測期間中、ポリメラーゼ連鎖反応（PCR）分野が最大となる見込み

予測期間中、ポリメラーゼ連鎖反応（PCR）分野が最大となる見込みです。これは、特定のDNA配列の増幅を可能にし、高感度かつ高精度の遺伝子発現解析を容易にします。個別化医療に対する需要の増加とゲノミクスの進歩が市場拡大に寄与しています。主要企業は革新的なPCR技術に投資し、製品ポートフォリオを強化しています。市場は、診断、治療、研究活動におけるPCRの応用拡大により、継続的な成長が見込まれています。

創薬＆開発セグメントは予測期間中最も高いCAGRが期待される

創薬＆開発分野は、予測期間中に最も高いCAGRが見込まれています。最先端の技術を活用し、研究者は遺伝子発現パターンを解析して潜在的な創薬ターゲットやバイオマーカーを特定します。この洗練されたアプローチにより、疾病メカニズムのより深い理解が可能となり、革新的な治療薬の開発に役立っています。ゲノミクスとバイオインフォマティクスの継続的な進歩により、この市場は精密医療と個別化治療戦略の未来を形作る上で不可欠な存在であり続けています。

最大のシェアを占める地域

予測期間中、北米が最大の市場シェアを占めると予測されます。同地域では、マイクロアレイや次世代シーケンシングプラットフォームを含む遺伝子発現プロファイリングツールに対する強い需要が見られます。市場成長の主な要因としては、ゲノミクスにおける研究活動の増加、慢性疾患の有病率の上昇、支持的な規制環境などが挙げられます。研究機関と業界プレイヤーのコラボレーションが遺伝子発現解析の技術革新をさらに促進し、市場情勢を確実に繁栄させています。

CAGRが最も高い地域：

アジア太平洋地域は、学術機関とバイオテクノロジー企業との共同研究により、予測期間中に最も高いCAGRを維持すると予測されています。.この地域の主なプレーヤーは、遺伝子発現解析のための革新的なソリューションを積極的に開発しており、ダイナミックで競合情勢に貢献しています。同地域がゲノムおよび分子生物学研究の著名な拠点となるにつれて、市場の上昇基調は今後も続くと予想されます。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 技術分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の遺伝子発現解析市場：製品別

• DNAチップ
• キットと試薬
• サービス
• その他の製品

第6章 世界の遺伝子発現解析市場：技術別

• 次世代シーケンシング（NGS）
• ポリメラーゼ連鎖反応（PCR）
• マイクロアレイ
• その他の技術

第7章 世界の遺伝子発現解析市場：用途別

• バイオテクノロジーと微生物学
• 臨床診断
• 創薬と開発
• その他の用途

第8章 世界の遺伝子発現解析市場：エンドユーザー別

• 学術研究機関
• 製薬会社およびバイオテクノロジー会社
• その他のエンドユーザー

第9章 世界の遺伝子発現解析市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Agilent Technologies
• GE Healthcare
• Illumina, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories
• F. Hoffmann-La Roche Ltd.
• Luminex Corp.
• Quest Diagnostics, Inc.
• PerkinElmer, Inc.
• Takara Bio, Inc.
• Catalent Inc.
• Promega Corp.
• Danaher Corp.
• QIAGEN
• Novogene Corporation
• Oxford Nanopore Technologies

List of Tables

• Table 1 Global Gene Expression Analysis Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 4 Global Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 5 Global Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 6 Global Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 7 Global Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 8 Global Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 9 Global Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 10 Global Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 11 Global Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 12 Global Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 13 Global Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 14 Global Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 15 Global Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 16 Global Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 17 Global Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 18 Global Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 19 Global Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 20 Global Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 21 North America Gene Expression Analysis Market Outlook, By Country (2021-2030) ($MN)
• Table 22 North America Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 23 North America Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 24 North America Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 25 North America Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 26 North America Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 27 North America Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 28 North America Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 29 North America Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 30 North America Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 31 North America Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 32 North America Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 33 North America Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 34 North America Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 35 North America Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 36 North America Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 37 North America Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 38 North America Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 39 North America Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 40 North America Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 41 Europe Gene Expression Analysis Market Outlook, By Country (2021-2030) ($MN)
• Table 42 Europe Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 43 Europe Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 44 Europe Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 45 Europe Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 46 Europe Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 47 Europe Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 48 Europe Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 49 Europe Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 50 Europe Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 51 Europe Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 52 Europe Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 53 Europe Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 54 Europe Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 55 Europe Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 56 Europe Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 57 Europe Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 58 Europe Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 59 Europe Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 60 Europe Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 61 Asia Pacific Gene Expression Analysis Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Asia Pacific Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 63 Asia Pacific Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 64 Asia Pacific Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 65 Asia Pacific Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 66 Asia Pacific Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 67 Asia Pacific Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 68 Asia Pacific Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 69 Asia Pacific Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 70 Asia Pacific Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 71 Asia Pacific Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 72 Asia Pacific Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 73 Asia Pacific Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 74 Asia Pacific Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 75 Asia Pacific Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 76 Asia Pacific Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 77 Asia Pacific Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 78 Asia Pacific Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 79 Asia Pacific Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 80 Asia Pacific Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 81 South America Gene Expression Analysis Market Outlook, By Country (2021-2030) ($MN)
• Table 82 South America Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 83 South America Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 84 South America Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 85 South America Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 86 South America Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 87 South America Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 88 South America Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 89 South America Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 90 South America Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 91 South America Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 92 South America Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 93 South America Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 94 South America Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 95 South America Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 96 South America Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 97 South America Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 98 South America Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 99 South America Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 100 South America Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 101 Middle East & Africa Gene Expression Analysis Market Outlook, By Country (2021-2030) ($MN)
• Table 102 Middle East & Africa Gene Expression Analysis Market Outlook, By Product (2021-2030) ($MN)
• Table 103 Middle East & Africa Gene Expression Analysis Market Outlook, By DNA Chips (2021-2030) ($MN)
• Table 104 Middle East & Africa Gene Expression Analysis Market Outlook, By Kits & Reagents (2021-2030) ($MN)
• Table 105 Middle East & Africa Gene Expression Analysis Market Outlook, By Services (2021-2030) ($MN)
• Table 106 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Products (2021-2030) ($MN)
• Table 107 Middle East & Africa Gene Expression Analysis Market Outlook, By Technology (2021-2030) ($MN)
• Table 108 Middle East & Africa Gene Expression Analysis Market Outlook, By Next Generation Sequencing (NGS) (2021-2030) ($MN)
• Table 109 Middle East & Africa Gene Expression Analysis Market Outlook, By Polymerase Chain Reaction (PCR) (2021-2030) ($MN)
• Table 110 Middle East & Africa Gene Expression Analysis Market Outlook, By Microarrays (2021-2030) ($MN)
• Table 111 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Technologies (2021-2030) ($MN)
• Table 112 Middle East & Africa Gene Expression Analysis Market Outlook, By Application (2021-2030) ($MN)
• Table 113 Middle East & Africa Gene Expression Analysis Market Outlook, By Biotech & Microbiology (2021-2030) ($MN)
• Table 114 Middle East & Africa Gene Expression Analysis Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
• Table 115 Middle East & Africa Gene Expression Analysis Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
• Table 116 Middle East & Africa Gene Expression Analysis Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 117 Middle East & Africa Gene Expression Analysis Market Outlook, By End User (2021-2030) ($MN)
• Table 118 Middle East & Africa Gene Expression Analysis Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
• Table 119 Middle East & Africa Gene Expression Analysis Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 120 Middle East & Africa Gene Expression Analysis Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Gene Expression Analysis Market is accounted for $4.9 billion in 2023 and is expected to reach $10.0 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Gene expression analysis refers to the study of the way genes are transcribed into RNA and translated into proteins, or the functional products they encode. It involves the measurement of the activity of genes in a particular cell, tissue, or organism under specific conditions. The analysis provides insights into wh Gene expression analysis for understanding the molecular mechanisms underlying various biological processes, including development, differentiation, response to stimuli, and diseases. By examining the patterns of gene expression, researchers can identify key genes involved in specific pathways, determine how genes are regulated, and gain insights into the molecular basis of diseases.

According to a 2016 survey conducted by the Federation of Indian Chambers of Commerce & Industry (FICCI), India faces an acute shortage of nearly 80% of Doctorate and Post Doctorate Scientists, a 20% shortage of people with a Master's degree, and a production staff shortage of 18% in the biotechnology sector.

Market Dynamics:

Driver:

Growing adoption of personalized medicine

The market is witnessing a surge in the adoption of personalized medicine, with a growing emphasis on tailoring treatments based on individual genetic profiles. This trend is driven by advancements in genomic research and technology, allowing for more precise analysis of gene expression patterns. As healthcare providers increasingly recognize the value of personalized approaches, the market is expected to expand further, offering innovative solutions for tailored therapies and diagnostics.

Restraint:

Shortage of trained professionals

The demand for skilled experts in interpreting and analyzing gene expression data far exceeds the current workforce supply. This shortage poses a significant challenge to harnessing the full potential of genomics in understanding diseases and developing targeted therapies. Addressing this gap through education and training initiatives is crucial to propel the field forward and unlock the transformative capabilities of gene expression analysis in healthcare and life sciences. The market faces a critical shortage of trained professionals, hindering advancements in genomic research and diagnostics.

Opportunity:

Rapid technological advancement

Innovations in high-throughput sequencing, single-cell analysis, and bioinformatics have propelled gene expression analysis to unprecedented levels of accuracy and efficiency. The continuous evolution of gene expression analysis technologies holds immense promise for advancing precision medicine and transforming our understanding of genetic regulation. The market has witnessed rapid technological advancement, revolutionizing the understanding of cellular function.

Threat:

High cost of the instruments

The sophisticated technology and specialized equipment required for gene expression analysis contribute to the elevated prices. This financial barrier may limit smaller laboratories or research facilities from fully engaging in comprehensive gene expression studies, potentially impacting the inclusivity and progress of scientific advancements in this field. Addressing cost concerns is crucial for fostering broader participation and innovation in gene expression analysis research. High cost of instruments is the factor hindering the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic has significantly impacted the market. Increased focus on understanding the virus's molecular mechanisms has driven demand for gene expression analysis tools. However, disruptions in supply chains, laboratory closures, and reduced funding for research have posed challenges. The market has witnessed both surges and declines, with shifts in priorities towards infectious disease research. Adapting to remote work and digital solutions has become crucial for companies in this sector to navigate the uncertainties and maintain momentum.

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period

The polymerase chain reaction (PCR) segment is expected to be the largest during the forecast period. This enables amplification of specific DNA sequences, facilitating gene expression analysis with high sensitivity and precision. Increasing demand for personalized medicine and advancements in genomics contribute to market expansion. Key players are investing in innovative PCR technologies, enhancing product portfolios. The market is poised for continuous growth, propelled by the expanding applications of PCR in diagnostics, therapeutics, and research endeavors.

The drug discovery & development segment is expected to have the highest CAGR during the forecast period

The drug discovery & development segment is expected to have the highest CAGR during the forecast period. Leveraging cutting-edge technologies, researchers analyze gene expression patterns to identify potential drug targets and biomarkers. This sophisticated approach enables a deeper understanding of disease mechanisms, aiding in the development of innovative therapeutics. With continuous advancements in genomics and bioinformatics, the market remains integral to shaping the future of precision medicine and personalized treatment strategies.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The region showcases a strong demand for gene expression profiling tools, including microarrays and next-generation sequencing platforms. Key factors contributing to market growth include increasing research activities in genomics, rising prevalence of chronic diseases, and a supportive regulatory environment. Collaborations between research institutions and industry players further propel innovation in gene expression analysis, ensuring a flourishing market landscape.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to the collaborations between academic institutions and biotechnology companies. . Key players in the region are actively developing innovative solutions for gene expression analysis, contributing to a dynamic and competitive landscape. The market's upward trajectory is expected to continue as the region becomes a prominent hub for genomics and molecular biology research.

Key players in the market

Some of the key players in Gene Expression Analysis market include Agilent Technologies, GE Healthcare, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd., Luminex Corp., Quest Diagnostics, Inc., PerkinElmer, Inc., Takara Bio, Inc., Catalent Inc., Promega Corp., Danaher Corp., QIAGEN, Novogene Corporation and Oxford Nanopore Technologies.

Key Developments:

In August 2023, The MinION MK1C, a new sequencer designed to be more reasonably priced and available to researchers, has been launched, according to an announcement from Oxford Nanopore Technologies. Gene expression analysis and RNA and DNA sequencing can both be done using the MinION MK1C.

In January 2023, The bioinformatics division of QIAGEN, QIAGEN Digital Insights (QDI), has just launched the QIAGEN CLC Genomics Workbench Premium, which eliminates the data-analysis bottleneck of next-generation sequencing.

Products Covered:

• DNA Chips
• Kits & Reagents
• Services
• Other Products

Technologies Covered:

• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Microarrays
• Other Technologies

Applications Covered:

• Biotech & Microbiology
• Clinical Diagnostics
• Drug Discovery & Development
• Other Applications

End Users Covered:

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Gene Expression Analysis Market, By Product

• 5.1 Introduction
• 5.2 DNA Chips
• 5.3 Kits & Reagents
• 5.4 Services
• 5.5 Other Products

6 Global Gene Expression Analysis Market, By Technology

• 6.1 Introduction
• 6.2 Next Generation Sequencing (NGS)
• 6.3 Polymerase Chain Reaction (PCR)
• 6.4 Microarrays
• 6.5 Other Technologies

7 Global Gene Expression Analysis Market, By Application

• 7.1 Introduction
• 7.2 Biotech & Microbiology
• 7.3 Clinical Diagnostics
• 7.4 Drug Discovery & Development
• 7.5 Other Applications

8 Global Gene Expression Analysis Market, By End User

• 8.1 Introduction
• 8.2 Academic and Research Institutes
• 8.3 Pharmaceutical and Biotechnology Companies
• 8.4 Other End Users

9 Global Gene Expression Analysis Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Agilent Technologies
• 11.2 GE Healthcare
• 11.3 Illumina, Inc.
• 11.4 Thermo Fisher Scientific, Inc.
• 11.5 Bio-Rad Laboratories
• 11.6 F. Hoffmann-La Roche Ltd.
• 11.7 Luminex Corp.
• 11.8 Quest Diagnostics, Inc.
• 11.9 PerkinElmer, Inc.
• 11.10 Takara Bio, Inc.
• 11.11 Catalent Inc.
• 11.12 Promega Corp.
• 11.13 Danaher Corp.
• 11.14 QIAGEN
• 11.15 Novogene Corporation
• 11.16 Oxford Nanopore Technologies